Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pamela L. Mendoza-Munoz
Observed names:
P. Mendoza-Munoz,
Pamela L Mendoza-Munoz,
Pamela Mendoza-Munoz
Institution:
Indiana University School of Medicine
Observed institutions:
Indiana University Indianapolis,
Indiana University School of Medicine,
Indiana University – Purdue University Indianapolis
ORCID:
0000-0002-7416-9875
Observed ORCID:
0000-0002-7416-9875
OpenAlex ID:
A5041383804
Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction
2020
·
Navnath S Gavande
, Pamela S VanderVere-Carozza
, et al.
·
Nucleic Acids Research
·
48
PDF
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
2023
·
Pamela L Mendoza-Munoz
, Navnath S Gavande
, et al.
·
NAR Cancer
·
9
Targeting DNA damage sensors for cancer therapy
2025
·
Matthew R. Jordan
, Pamela L. Mendoza-Munoz
, et al.
·
DNA repair
·
5
Impact of Optimized Ku–DNA Binding Inhibitors on the Cellular and In Vivo DNA Damage Response
2024
·
Pamela L. Mendoza-Munoz
, Narva Deshwar Kushwaha
, et al.
·
Cancers
·
4
PDF
Ku-DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
2022
·
P. Mendoza-Munoz
, N.S. Gavande
, et al.
·
European Journal of Cancer
·
1
PDF
Abstract 236: Targeting DNA damage sensors (DDS) to enhance Osimertinib response in EGFR-driven cancers.
2026
·
Pamela L. Mendoza-Munoz
, Madison E. Gerbig
, et al.
·
Cancer Research
Structure-Based Design and Development of 2-Oxindole Derivatives as Next Generation Ku-DNA Binding Inhibitors (Ku-DBi’s) for Cancer Therapy.
2025
·
Narva Deshwar Kushwaha
, Dineshsinha Chauhan
, et al.
·
ChemRxiv
PDF
Design, synthesis, and structure–activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitors
2025
·
Narva Deshwar Kushwaha
, Pamela VanderVere-Carozza
, et al.
·
RSC Medicinal Chemistry
PDF
347 (PB335): Optimized Ku-DNA binding inhibitors impact the cellular and in vivo DNA damage response to DSB-inducing therapies
2024
·
P. Mendoza-Munoz
, N.D. Kushwaha
, et al.
·
European Journal of Cancer
Abstract 416: Development of substituted oxindole derivatives as a Ku-targeted DNA-PK inhibitors for cancer therapy
2024
·
Dineshsinha Chauhan
, Pamela L. Mendoza-Munoz
, et al.
·
Cancer Research
Abstract 7128: Novel Ku-DNA binding inhibitors impact on the cellular and in vivo DNA damage response to radio- and radiomimetic-therapy
2024
·
Pamela L. Mendoza-Munoz
, Dineshsinha Chauhan
, et al.
·
Cancer Research
Abstract A027: Development of small molecule inhibitors of the Ku-DNA interaction: Impacts on NHEJ, DDR signaling, optimizing genome editing technologies, and therapeutic intervention for the treatment of cancer
2024
·
John J. Turchi
, Pamela L. Mendoza-Munoz
, et al.
·
Cancer Research
Abstract B068: Modulation of the DNA damage response by novel Ku-DNA binding inhibitors enhances cellular effects of DNA-double strand break inducing agents
2023
·
Pamela L Mendoza-Munoz
, Dineshsinha Chauhan
, et al.
·
Molecular Cancer Therapeutics
Abstract 2596: Impact of novel Ku-DNA binding inhibitors on the DNA DSBs-induced DNA damage response
2022
·
Pamela L. Mendoza-Munoz
, Navnath S. Gavande
, et al.
·
Cancer Research
Abstract PO-023: Impact of a novel Ku-DNA binding inhibitor on the IR-induced DNA damage response
2021
·
Pamela Mendoza-Munoz
, Navnath S. Gavande
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
15
Citation count:
67
H-index:
4
I10-index:
1
Year
Topic
Type
